These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 338106)

  • 1. Viloxazine: assessment of potential rapid antidepressant action.
    Edwards JG
    Br Med J; 1977 Nov; 2(6098):1327. PubMed ID: 338106
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trials of viloxazine in depressive states].
    Fontan M; Goudemand M; Pellerin-Millecamps E
    Encephale; 1979; 5(3):243-9. PubMed ID: 385296
    [No Abstract]   [Full Text] [Related]  

  • 3. Viloxazine and amitriptyline in depressive illness. A double blind controlled trial in general practice.
    Lennox IG; Asbury JF; Couldrick WG; Beswick KB
    Practitioner; 1978 Jan; 220(1315):153-6. PubMed ID: 343090
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraindividual comparison of the antidepressant effectivity of viloxazine and maprotiline.
    Dostal T; Kabes J
    Act Nerv Super (Praha); 1978 Dec; 20(4):252-3. PubMed ID: 735720
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative study of viloxazine and imipramine (author's transl)].
    Floru L; Tegeler J
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):313-20. PubMed ID: 386389
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly.
    Moizeszowicz J; Subirá S
    J Clin Pharmacol; 1977 Jan; 17(1):81-3. PubMed ID: 319120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viloxazine in the treatment of depression: psychophysical measures and clinical response.
    Amin MM; Ban TA; Lehmann HE; Khan P
    Psychopharmacol Bull; 1978 Jan; 14(1):33-5. PubMed ID: 625536
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of maprotiline (Ludiomil) and viloxazine in the management of depressed patients in general practice.
    Lomas DM
    J Int Med Res; 1977; 5 Suppl 4():39-50. PubMed ID: 338401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of viloxazine and imipramine in the treatment of depressive states.
    Elwan O
    J Int Med Res; 1980; 8(1):7-17. PubMed ID: 7358207
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double-blind trial of 2 antidepressive drugs].
    De León O; Kravcio JT; Sánchez C
    Acta Psiquiatr Psicol Am Lat; 1977 Sep; 23(3):215-20. PubMed ID: 341650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Viloxazine: its antidepressant action and lack of concomitant anticholinergic effect].
    Marchetti G; Amaducci L; Faravelli C; Matteini P; Pazzagli A
    Riv Patol Nerv Ment; 1977; 98(2):88-98. PubMed ID: 616014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Viloxazine. Aspects of the therapeutic effect of the antidepressive agent viloxazine (Vivalan ICI) in the opinion of practicing neurologists].
    Jungkunz G
    MMW Munch Med Wochenschr; 1982 Aug; 124(32-33):712-4. PubMed ID: 6813688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
    Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical profile and serum concentration of viloxazine as compared to amitriptyline.
    Müller-Oerlinghausen B; Rüther E
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):321-37. PubMed ID: 386390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jun; 13(6):401-21. PubMed ID: 324751
    [No Abstract]   [Full Text] [Related]  

  • 18. The therapeutic effect of viloxazine (Vivalan ICI) in hospitalized depressive patients -- a multicenter study.
    Kabes J; Náhunek K; Molcan J; Hynek K; Dostal T; Svestka J; Faltus F; Caplová T
    Act Nerv Super (Praha); 1978 Dec; 20(4):251-2. PubMed ID: 735719
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of the clinical trial with viloxazine (Vivalan ICI). A part of the multicentre study (author's transl)].
    Kabes J; Dostal T
    Cesk Psychiatr; 1979 Aug; 75(4):225-31. PubMed ID: 393416
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic use of viloxazine (Vivalan ICI) in depressed hospital out-patients (author's transl)].
    Kabes J; Dostal T
    Cesk Psychiatr; 1976 Dec; 72(6):384-9. PubMed ID: 1000703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.